p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer
- PMID: 11237531
- DOI: 10.1006/excr.2000.5143
p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer
Abstract
A major function of p27, also known as Kip1, is to bind and inhibit cyclin/cyclin-dependent kinase complexes, thereby blocking cell cycle progression. As p27 operates at the heart of the cell cycle, it is perhaps not surprising that it is emerging as a key player in multiple cell fate decisions including proliferation, differentiation, and cell death. The central role of p27 makes it important in a variety of disease processes that involve aberrations in cellular proliferation and other cell fates. Most notable among these processes is neoplasia. A large number of studies have reported that p27 expression is frequently downregulated in human tumors. In most tumor types, reduced p27 expression correlates with poor prognosis, making p27 a novel and powerful prognostic marker. In addition to these practical implications, murine and tissue culture models have shown that p27 is a potent tumor suppressor gene for multiple epithelially derived neoplasias. Loss of p27 cooperates with mutations in several oncogenes and tumor suppressor genes to facilitate tumor growth, indicating that p27 may be a "nodal point" for tumor suppression. In contrast to most tumor suppressor genes studied to date, which are recessive at the cellular level, p27 is haploinsufficient for tumor suppression. The fact that tumor suppression by p27 is critically dependent on the absolute level of p27 expression indicates that p27 acts as a rheostat rather than as an on/off switch to control growth and neoplasia.
Copyright 2001 Academic Press.
Similar articles
-
Multiple functions of p27(Kip1) and its alterations in tumor cells: a review.J Cell Physiol. 2000 Apr;183(1):18-27. doi: 10.1002/(SICI)1097-4652(200004)183:1<18::AID-JCP3>3.0.CO;2-S. J Cell Physiol. 2000. PMID: 10699962 Review.
-
p27 Expression, a cyclin dependent kinase inhibitor in breast carcinoma.Adv Clin Path. 1999 Oct;3(4):119-27. Adv Clin Path. 1999. PMID: 10936889 Review.
-
Low expression of p27(Kip1), a cyclin-dependent kinase inhibitor, is a marker of poor prognosis in synovial sarcoma.Cancer. 2001 Mar 1;91(5):1005-12. Cancer. 2001. PMID: 11251953
-
Skp2 is oncogenic and overexpressed in human cancers.Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5043-8. doi: 10.1073/pnas.081474898. Epub 2001 Apr 17. Proc Natl Acad Sci U S A. 2001. PMID: 11309491 Free PMC article.
-
Prognostic significance of p27/kip1 and apoptosis in patients with colorectal carcinoma.Oncol Rep. 2003 Jul-Aug;10(4):827-31. Oncol Rep. 2003. PMID: 12792730
Cited by
-
An age-and-cyclin-structured cell population model for healthy and tumoral tissues.J Math Biol. 2008 Jul;57(1):91-110. doi: 10.1007/s00285-007-0147-x. Epub 2007 Dec 7. J Math Biol. 2008. PMID: 18064465
-
p110δ PI3 kinase pathway: emerging roles in cancer.Front Oncol. 2013 Mar 1;3:40. doi: 10.3389/fonc.2013.00040. eCollection 2013. Front Oncol. 2013. PMID: 23459844 Free PMC article.
-
Proteomics identifies neddylation as a potential therapy target in small intestinal neuroendocrine tumors.Oncogene. 2019 Oct;38(43):6881-6897. doi: 10.1038/s41388-019-0938-8. Epub 2019 Aug 12. Oncogene. 2019. PMID: 31406256
-
Akt1 sequentially phosphorylates p27kip1 within a conserved but non-canonical region.Cell Div. 2006 Jun 16;1:11. doi: 10.1186/1747-1028-1-11. Cell Div. 2006. PMID: 16780593 Free PMC article.
-
Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype.Genes Dev. 2007 Jul 15;21(14):1731-46. doi: 10.1101/gad.1556607. Epub 2007 Jul 12. Genes Dev. 2007. PMID: 17626791 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous